Using Artificial Intelligence Models for Predicting The Need for Intubation and Successful Weaning From Mechanical Ventilation in ICU Patients
NCT ID: NCT07065838
Last Updated: 2025-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
600 participants
OBSERVATIONAL
2025-10-01
2027-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
And also assess whether AI-assisted decisions improve patient outcomes (e.g., reduced intubation delays, shorter ventilation duration).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Duration of Mechanical Ventilation in ARDS
NCT05993377
Development of a Scoring and Prediction Model for Weaning Success in ARDS Patients Using Ventilation Parameters Combined with Artificial Intelligence and Deep Learning Techniques
NCT06751693
Prediction of the Spontaneous Breathing Test Success Using Biosignal and Biomarker in Critical Care Unit by a Machine Learning Approach
NCT05886803
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
NCT05668637
Artificial Intelligence in Categorizing the Severity of Oxygenation by Incorporating the PEEP Into the Definition of ARDS in Ventilated Patients
NCT05371314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Also, estimating an appropriate weaning time from mechanical ventilation is an essential clinical decision in critical care. Premature attempts to extubate patients increase the risk of ventilator-associated pneumonia, prolonged intensive care unit (ICU) stay, and mortality. Meanwhile, an unnecessarily prolonged duration of mechanical ventilation causes an enormous economic health burden and is associated with deteriorated clinical outcomes .
Previously proposed weaning indices have shown conflicting results, as over one-quarter of patients require reintubation despite meeting the criteria for such indices, such as the rapid shallow breathing index (RSBI) . Therefore, an accurate prediction tool for deciding when patients are ready for extubation is critical for managing patients with respiratory failure.
Artificial intelligence models have emerged as promising solutions for tackling these challenges. These technologies have the potential to learn from data and predict the optimal intubation timing. Unlike medical professionals, machine learning models are not affected by personal emotions.
Regarding intubation prediction; AI models incorporating time-series analysis of respiratory rate variability, oxygen saturation trends, and evolving PaO2/FiO2 ratios can predict impending respiratory failure with greater accuracy than conventional clinical assessment. Also, regarding weaning decision support; Machine learning algorithms analyzing integrated parameters during spontaneous breathing trials demonstrate superior prediction of extubation success compared to traditional weaning indices. Recent studies show AI-guided protocols can reduce ventilator days by 1.8 days (95% CI 0.5-3.1) without increasing reintubation rates.
These systems function as cognitive aids, processing multidimensional data at a scale beyond human capacity while preserving clinician judgment. Once the model has done enough learning, the trained model can be easily deployed with low costs at various ICUs.
This study aims to using artificial intelligence (AI) approach to build a model to determine the optimal timing of intubation and optimal timing of weaning from MV for ICU patients, and compare outcomes with these which depend on clinicians' decision. Then assess whether AI-assisted decisions improve patient outcomes (e.g., reduced intubation delays, shorter ventilation duration).
Study tools include collecting patients data and AI model development;
1. Data collection:
All participates will be subjected to
1. Baseline data: Demographics ( age, sex, weight, length) , comorbidities (DM, HTNs ,chronic kidney disease… ), APACHE II score, reason for mechanical ventilation.
2. Daily data:
1. Resolution of the underlying condition: The primary reason for mechanical ventilation should be resolved or significantly improved.
2. Hemodynamic stability:
blood pressure and heart rate without significant vasopressor support. c- oxygenation: - PaO₂ ≥ 60 mmHg on FiO₂ ≤ 0.4. - PEEP ≤ 5-8 cm H₂O. - Oxygen saturation (SpO₂) ≥ 90%. d- ventilation: - PaCO₂ within normal limits or at the patient's baseline. - pH ≥ 7.25.
\- Normal electrolyte levels: K, Mg, phosphate
\- fluid balance.
* Normal metabolic status: No significant acidosis or alkalosis.
* hemoglobin levels: \> 7 g/dL
e. Respiratory Mechanics
* (RR): \< 35 breaths/min.
* Tidal volume : \> 5 mL/kg ideal body weight.
* Minute ventilation (VE): \< 10-15 L/min.
* Rapid shallow breathing index : \< 105 breaths/min/L (measured during a spontaneous breathing trial).
* Endotracheal cuff leak test. f. Neurological Status
* mental status: Patient should be awake, alert, and able to protect their airway.
* Cough and gag reflex
* Minimal sedation g. Others
* Infection control: No active infection or fever that could impair weaning.
* Pain management 3- Outcome data: Duration of ventilation, ICU length of stay, complications, reintubation rates.
b.AI model development :
1. model choice
2. model training and validation; Split Data 70% training, 15% validation, 15% testing
3. performance metrics , AUC-ROC, sensitivity , specificity, F1-score, calibration (Brier score).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults (≥18 years) receiving mechanical ventilation for \>24 hours and deemed ready for weaning.
Exclusion Criteria
* \- Patients with irreversible neurological conditions affecting weaning
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatema Medhat Ahmed
Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI and mechanical ventilation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.